🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Honored to host Dame Lesley who commanded a packed audience⁩ for the 20th Young&Strong Forum for patients and families ⁦Dana-Farber’s Breast Oncology Center⁩ ⁦Dana-Farber⁩ ⁦Lesley Fallowfield⁩

Research by Dana-Farber Cancer Institute investigators has encouraging news for young women who have survived #BreastCancer and want to have children. #pregnancy #YoungAdultBreastCancer #BreastCancerAwareness Ann Partridge MD, MPH Dana-Farber’s Breast Oncology Center dana-farber.org/newsroom/news-…

Powerhouse panel at the The Breast Cancer Research Foundation symposium: Drs. Larry Norton, Lisa Carey, MD, ScM, FASCO, Robert Vonderheide, Abenaa Brewster, and Judy Garber. Thank you to BCRF for your incredible support of breast cancer research!

The open-label, international, multicenter, randomized phase III AFT-65/ASCENT-05/OptimICE-RD trial will determine whether the combination of #SacituzumabGovitecan and #Pembrolizumab can improve iDFS compared with pembrolizumab, alone or in combination with capecitabine, in

New 📰 on patient-reported outcomes, and perceptions and knowledge about recurrence in women with hormone receptor-positive #BreastCancer. 👉pubmed.ncbi.nlm.nih.gov/39432162/ ✍️Shoshana Rosenberg Nancy Lin, MD Ann Partridge MD, MPH Eric Winer, MD Heather Parsons #survivorship

Thank you to Ann Partridge MD, MPH Harvard Medical School Dana-Farber for joining us to present #GrandRounds on the care of young adults with #breastcancer and the unique challenges they face. Watch her talk now youtube.com/watch?v=izOlDM…. #bcsm Smilow Cancer Hospital Yale School of Medicine Yale New Haven Hosp YaleBreastCancer

Not every day that a Nobel prize winner will be delivering a talk at SABCS opening ceremony. Excited to hear his talk KaelinLab Carlos L. Arteaga, M.D. AACR @UTHealthSAMDA

The IBC forum is this morning-- a terrific program to learn more about inflammatory breast cancer. Thanks to Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 and team for organizing! All are welcome: redcap.partners.org/redcap/surveys… Dana-Farber’s Breast Oncology Center Dana-Farber News #bcsm

congratulations Judy. So well-deserved.Alliance for Clinical Trials in Oncology

🎉Big win for MA patients-saving lives, & reducing disparities! Starting 2026, breast imaging will be covered with NO out-of-pocket costs. Thank you to Gov. Maura Healey Dana-Farber’s Breast Oncology Center & all advocates! Together, we’re making a difference. #MACancerCares #BreastCancerAwareness

We are proud to announce that four of our #BreastCancer physician-scientists made the #HighlyCited2024 researchers list, released today by Clarivate for Academia & Government. Congratulations to ✨Dr. Myles Brown ✨Dr. Nancy Lin (Nancy Lin, MD) ✨Dr. Geoffrey Shapiro (Geoffrey Shapiro MD PhD) ✨Dr. Sara Tolaney

Congratulations David Barbie and the Dana-Farber's Lowe Center for Thoracic Oncology team! They were awarded a $2.5 million, four-year research grant from the Lung Cancer Research Foundation and the IASLC. Read more here: bit.ly/48XoOAI

So proud of Dr. Caroline Block, recipient of the Arthur Skarin Award and Dr. Geoff Shapiro Geoffrey Shapiro MD PhD, recipient of the Distinguished Researcher Award from the Massachusetts Society of Clinical Oncology Dana-Farber’s Breast Oncology Center Dana-Farber The Center for BRCA and Related Genes Dana-Farber’s CCTI 👏🏻👏🏻👏🏻

Just published in Journal of Clinical Oncology the updated ASCO guidelines on fertility preservation in people with #cancer: a must read for all colleagues involved in cancer care to increase awareness on #oncofertility issues OncoAlert Ann Partridge MD, MPH Oncofertility Link: ascopubs.org/doi/10.1200/JC…

Thanks to the incredible team at Foundation Medicine for making our project possible! Stay tuned for interesting correlates of response and resistance to T-DM1, T-DXd, and SG in the Flatiron database at ASCO 🙌🏻 #ADC #breastcancer ASCO Conquer Cancer, the ASCO Foundation

Can’t miss CME opportunity!

Amazing start of #ESMObreastBCY with full room showing the importance and interest in care for young women with breast cancer 💕 Matteo Lambertini, MD PhD ESMO - Eur. Oncology Ann Partridge MD, MPH FabriceAndre

Great overview by Fedro Peccatori MD, PhD on how to manage the side effects of estrogen deprivation therapy in young women with #BreastCancer during #ESMOBreastBCY…looking forward to new data expected at #ASCO25 on improving vasomotor symptoms ESMO - Eur. Oncology OncoAlert #ESMOBreast25 #ESMOAmbassadors

Matteo Lambertini, MD PhD starts presenting the first results of the survey answered by 18 expert panelists focused in the treatment of young pts Topic 1: are we giving too much or not enough adjuvant OFS? Age and nodal involvement are main factors considered in deciding adj ET OncoAlert

It’s been an honor and privilege to have been part of the faculty of BCY at #ESMOBreast25 A growing community working for the young patients with BC. Thank you Matteo Lambertini, MD PhD and Dr Paluch-Shimon 👏👏👏 Ann Partridge MD, MPH Kevin Kalinsky, MD, MS, FASCO Peter Dubsky Rebecca Dent Icro Meattini